November 24, 2014
TraceLink Inc., the leader in protecting patient safety and enabling health for global Life Sciences, today announced that customers using its Product Track transaction history management system and Life Sciences Cloud platform are now live with the “Big Three” pharmaceutical distributors—AmerisourceBergen, Cardinal Health, and McKesson – and officially shipping commercial goods with DSCSA compliant Advance Shipping Notices (ASNs) based on HDMA guidelines. TraceLink is currently the only company with a live solution in production that meets the preferred specifications established by each member of the Big Three for receiving DSCSA Transaction Information (TI), Transaction History (TH), and Transaction Statement (TS) documents—and able to offer any company in the pharmaceutical supply chain a 5-day implementation timeframe to meet the January 1, 2015 compliance deadline under the Drug Supply Chain Security Act (DSCSA).
“Today marks a significant milestone—for our customers, and the Life Sciences industry,” said Shabbir Dahod, president and CEO of TraceLink. “Early on, we learned that the Big Three pharma distributors each had different expectations for how they wanted to receive compliant ASNs, and we’re pleased to be first to market with a live solution that meets all of their distinct needs. Equally important is our program that enables any business in the pharmaceutical supply chain to achieve January 1 DSCSA compliance in just a week. This is critical for the hundreds of pharmaceutical companies that are still struggling with their plans, because TraceLink will not only have them ready in 5 business days—we’ll ensure that in the same period they’re able to ship commercial goods to the Big Three with all of the required DSCSA compliant ASNs.”
As the January 1, 2015 deadline approaches, TraceLink’s Product Track software and Life Sciences Cloud platform have quickly become the preferred track and trace solutions for conducting DSCSA compliant transactions between all pharmaceutical supply chain trading partners, ensuring that critical medicines reach patients in the safest, most secure, and most timely manner. With TraceLink’s proven solution that achieves DSCSA compliance interoperability with the Big Three—and the thousands of other companies on the TraceLink network, new customers who connect to the Life Sciences Cloud will be instantly linked to any of the Big Three distributors with whom they have trading relationships for immediate shipping of commercial goods with DSCSA compliant ASNs.
Specifically designed for pharmaceutical manufacturers, wholesalers, repackagers and dispensers, the TraceLink Life Sciences Cloud connects tens of thousands of trading partners to deliver end-to-end DSCSA compliance. Companies who are considering TraceLink to help them meet January 1, 2015 DSCSA deadlines typically find that over 90% of the suppliers and trading partners they do business with are already on the TraceLink network.
To understand how TraceLink can help you prepare for DSCSA and implement its proven and cost-effective solution used by the majority of top-20 pharmaceutical companies, visit www.tracelink.com.
TraceLink protects patients and enables health for companies across the global Life Sciences supply network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is trusted by fourteen of the top-20 pharmaceutical companies and businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. FirstMark’s mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. FirstMark has built a deeply engaged community among the extraordinary teams in the FirstMark network to spread ideas and opportunities. FirstMark is privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit FirstMark in New York City or online at firstmarkcap.com and @FirstMarkCap.